March 21, 2022 – BA.2 Omicron Subvariant’s Recent Success, The Unclear Future Of Additional Booster Shots episode artwork

EPISODE · Mar 22, 2022 · 18 MIN

March 21, 2022 – BA.2 Omicron Subvariant’s Recent Success, The Unclear Future Of Additional Booster Shots

from COVID in L.A. · host LAist Studios

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Dean Blumberg, professor of medicine and chief of Pediatric Infectious Diseases at UC Davis Children’s Hospital.  Topics today include:  Dr. Anthony Fauci: uptick in cases likely due to BA.2 subvariant of Omicron.  New study sheds light on BA.2’s recent success.  L.A. Times: Omicron surge hit SoCal harder than the rest of the state.  The unclear future of additional booster shots.  Could the BAFTA weekend have caused an uptick in COVID-19 cases in the entertainment industry?  As mask requirements ease, teens find themselves anxious on whether to continue masking.    This program is made possible in part by the Corporation for Public Broadcasting, a private corporation funded by the American people.    

Episode metadata supplied by the publisher feed · Published Mar 22, 2022

Embed this episode

NOW PLAYING

March 21, 2022 – BA.2 Omicron Subvariant’s Recent Success, The Unclear Future Of Additional Booster Shots

0:00 18:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of COVID in L.A.?

This episode is 18 minutes long.

When was this COVID in L.A. episode published?

This episode was published on March 22, 2022.

Can I download this COVID in L.A. episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!